Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients

Cancer Immunology, Immunotherapy

Volumn 61, Issue 2, 2012, Pages 255-263

  Filipazzi, Paola ^a   Huber, Veronica ^a   Rivoltini, Licia ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Cancer vaccines; CD14 +HLA DR neg low; CITIM 2011; Myeloid dysfunctions; T cells; Tumour exosomes

Indexed keywords

AFLIBERCEPT; BEVACIZUMAB; CD11B ANTIGEN; CELL PROTEIN; COLECALCIFEROL; PROTEIN GR1; RETINOIC ACID; SUNITINIB; UNCLASSIFIED DRUG;

CANCER GROWTH; CANCER PATIENT; CANCER STAGING; CARCINOGENESIS; CELL HETEROGENEITY; CELLULAR IMMUNITY; DISEASE COURSE; DRUG MECHANISM; HEAD AND NECK CANCER; HUMAN; IMMUNE DEFICIENCY; IMMUNOMODULATION; IMMUNOREGULATION; KIDNEY CARCINOMA; LYMPHOCYTE FUNCTION; MELANOMA; MOLECULAR INTERACTION; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SOLID TUMOR; SUPPRESSOR CELL; T LYMPHOCYTE SUBPOPULATION; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOSUPPRESSION; IMMUNOTHERAPY; MICE; MYELOID CELLS; NEOPLASMS; TUMOR ESCAPE; TUMOR MICROENVIRONMENT;

EID: 84856706929     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-011-1161-9     Document Type: Review

References (56)

1. D Hanahan RA Weinberg 2011 Hallmarks of cancer: the next generation Cell 144 5 646 674 21376230 10.1016/j.cell.2011.02.013 1:CAS:528:DC%2BC3MXjsFeqtrk%3D
2. DI Gabrilovich S Nagaraj 2009 Myeloid-derived suppressor cells as regulators of the immune system Nat Rev Immunol 9 3 162 174 19197294 10.1038/nri2506 1:CAS:528:DC%2BD1MXhsFeqsbw%3D
3. L Yang J Huang X Ren AE Gorska A Chytil M Aakre DP Carbone LM Matrisian A Richmond PC Lin HL Moses 2008 Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis Cancer Cell 13 1 23 35 18167337 10.1016/j.ccr.2007.12.004 1:CAS:528: DC%2BD1cXnsVKnuw%3D%3D (Pubitemid 350309741)
4. JI Youn S Nagaraj M Collazo DI Gabrilovich 2008 Subsets of myeloid-derived suppressor cells in tumor-bearing mice J Immunol 181 8 5791 5802 18832739 1:CAS:528:DC%2BD1cXhtF2hsL3I
5. JI Youn DI Gabrilovich 2010 The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity Eur J Immunol 40 11 2969 2975 21061430 10.1002/eji.201040895 1:CAS:528:DC%2BC3cXhtl2isbfK
6. C Murdoch M Muthana SB Coffelt CE Lewis 2008 The role of myeloid cells in the promotion of tumour angiogenesis Nat Rev Cancer 8 8 618 631 18633355 10.1038/nrc2444 1:CAS:528:DC%2BD1cXovV2lsrY%3D
7. G Parmiani C Castelli M Santinami L Rivoltini 2007 Melanoma immunology: past, present and future Curr Opin Oncol 19 2 121 127 17272984 10.1097/CCO.0b013e32801497d7 (Pubitemid 46204351)
8. L Rivoltini P Canese V Huber M Iero L Pilla R Valenti S Fais F Lozupone C Casati C Castelli G Parmiani 2005 Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control? Expert Opin Biol Ther 5 4 463 476 15934826 10.1517/14712598.5.4.463 1:CAS:528:DC%2BD2MXjt1yntb4%3D (Pubitemid 40593331)
9. F Hillen CI Baeten A van de Winkel D Creytens DW van der Schaft V Winnepenninckx AW Griffioen 2008 Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma Cancer Immunol Immunother 57 1 97 106 17602225 10.1007/s00262-007-0353-9 (Pubitemid 350043652)
10. TO Jensen H Schmidt HJ Møller M Høyer MB Maniecki P Sjoegren IJ Christensen T Steiniche 2009 Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I/II melanoma J Clin Oncol 27 20 3330 3337 19528371 10.1200/JCO.2008.19.9919
11. P Filipazzi R Valenti V Huber L Pilla P Canese M Iero C Castelli L Mariani G Parmiani L Rivoltini 2007 Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine J Clin Oncol 25 18 2546 2553 17577033 10.1200/JCO.2006.08.5829 1:CAS:528: DC%2BD2sXotV2mt7Y%3D (Pubitemid 47041228)
12. P Serafini R Carbley KA Noonan G Tan V Bronte I Borrello 2004 High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells Cancer Res 64 17 6337 6343 15342423 10.1158/0008-5472.CAN-04-0757 1:CAS:528: DC%2BD2cXntFClt7k%3D (Pubitemid 39129439)
13. G Parmiani C Castelli L Pilla M Santinami MP Colombo L Rivoltini 2007 Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients Ann Oncol 18 2 226 232 17116643 10.1093/annonc/mdl158 1:STN:280:DC%2BD2s%2Fotlekug%3D%3D (Pubitemid 46323086)
14. TF Greten MP Manns F Korangy 2011 Myeloid derived suppressor cells in human diseases Int Immunopharmacol 11 7 802 807 21237299 10.1016/j.intimp.2011. 01.003 1:CAS:528:DC%2BC3MXntVyjurk%3D
15. S Mandruzzato S Solito E Falisi S Francescato V Chiarion-Sileni S Mocellin A Zanon CR Rossi D Nitti V Bronte P Zanovello 2009 IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients J Immunol 182 10 6562 6568 19414811 10.4049/jimmunol.0803831 1:CAS:528:DC%2BD1MXltlymt7Y%3D
16. AS Dugast T Haudebourg F Coulon M Heslan F Haspot N Poirier R Vuillefroy de Silly C Usal H Smit B Martinet P Thebault K Renaudin B Vanhove 2008 Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion J Immunol 180 12 7898 7906 18523253 1:CAS:528:DC%2BD1cXntVemtbk%3D
17. S Kusmartsev E Eruslanov H Kübler T Tseng Y Sakai Z Su S Kaliberov A Heiser C Rosser P Dahm D Siemann J Vieweg 2008 Oxidative stress regulates expression of VEGFR1 in myeloid cells: link to tumor-induced immune suppression in renal cell carcinoma J Immunol 181 1 346 353 18566400 1:CAS:528: DC%2BD1cXnsVGjtbs%3D
18. J Finke J Ko B Rini P Rayman J Ireland P Cohen 2011 MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy Int Immunopharmacol 11 7 856 861 21315783 10.1016/j.intimp.2011.01.030 1:CAS:528:DC%2BC3MXntVyisrw%3D
19. I Poschke D Mougiakakos J Hansson GV Masucci R Kiessling 2010 Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign Cancer Res 70 11 4335 4345 20484028 10.1158/0008-5472.CAN-09-3767 1:CAS:528:DC%2BC3cXmslWgsbY%3D
20. CM Diaz-Montero ML Salem MI Nishimura E Garrett-Mayer DJ Cole AJ Montero 2009 Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy Cancer Immunol Immunother 58 1 49 59 18446337 10.1007/s00262-008- 0523-4 1:CAS:528:DC%2BD1cXht1yqs7bN
21. -/low myeloid-derived suppressor cells and decreased level of dendritic cells in patients with multiple myeloma Scand J Immunol 72 6 540 547 21044128 10.1111/j.1365-3083.2010.02463.x 1:CAS:528:DC%2BC3cXhsFyqurzP
22. B Hoechst LA Ormandy M Ballmaier F Lehner C Krüger MP Manns TF Greten F Korangy 2008 A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells Gastroenterology 135 1 234 243 18485901 10.1053/j.gastro.2008.03.020 1:CAS:528:DC%2BD1cXps1Wltb0%3D (Pubitemid 351899008)
23. S Vuk-Pavlović PA Bulur Y Lin R Qin CL Szumlanski X Zhao AB Dietz 2010 Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer Prostate 70 4 443 455 19902470
24. RA Wilcox DA Wada SC Ziesmer SF Elsawa NI Comfere AB Dietz AJ Novak TE Witzig AL Feldman MR Pittelkow SM Ansell 2009 Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells Blood 114 14 2936 2944 19671921 10.1182/blood-2009-05-220111 1:CAS:528:DC%2BD1MXht12qur%2FK
25. AH Zea PC Rodriguez MB Atkins C Hernandez S Signoretti J Zabaleta D McDermott D Quiceno A Youmans A O'Neill J Mier AC Ochoa 2005 Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion Cancer Res 65 8 3044 3048 15833831 1:CAS:528:DC%2BD2MXjt1yks7g%3D (Pubitemid 40524582)
26. S Kusmartsev Y Nefedova D Yoder DI Gabrilovich 2004 Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species J Immunol 172 2 989 999 14707072 1:CAS:528:DC%2BD2cXnvVGl (Pubitemid 38113758)
27. S Ostrand-Rosenberg 2010 Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity Cancer Immunol Immunother 59 1593 1600 20414655 10.1007/s00262-010-0855-8
28. J Schmielau OJ Finn 2001 Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients Cancer Res 61 12 4756 4760 11406548 1:CAS:528:DC%2BD3MXks1Grtbg%3D (Pubitemid 32691887)
29. M Munder F Mollinedo J Calafat J Canchado C Gil-Lamaignere JM Fuentes C Luckner G Doschko G Soler K Eichmann FM Müller AD Ho M Goerner M Modolell 2005 Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity Blood 105 6 2549 2556 15546957 10.1182/blood-2004-07-2521 1:CAS:528:DC%2BD2MXisFSkur4%3D (Pubitemid 40387058)
30. S Kusmartsev Z Su A Heiser J Dannull E Eruslanov H Kübler D Yancey P Dahm J Vieweg 2008 Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma Clin Cancer Res 14 24 8270 8278 19088044 10.1158/1078-0432.CCR-08-0165 1:CAS:528:DC%2BD1cXhsV2it7jF
31. S Brandau S Trellakis K Bruderek D Schmaltz G Steller M Elian H Suttmann M Schenck J Welling P Zabel S Lang 2011 Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties J Leukoc Biol 89 2 311 317 21106641 10.1189/jlb.0310162 1:CAS:528:DC%2BC3MXkvVWqs7Y%3D
32. + cells in tumor-bearing host directly promotes tumor angiogenesis Cancer Cell 6 4 409 421 15488763 10.1016/j.ccr.2004.08.031 1:CAS:528:DC%2BD2cXpsF2rtLo%3D (Pubitemid 39361441)
33. Borden EC, Ko Smith J, Rayman PA, Jacobs B, Ireland J, Lindner D, Finke J (2010) Dual mechanicistic function of MDSC subsets in melanoma resistence. J Clin Oncol Vol 28, no 15 suppl
34. MG Lechner C Megiel SM Russell B Bingham N Arger T Woo AL Epstein 2011 Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines J Transl Med 9 90 21658270 10.1186/1479-5876-9-90 1:CAS:528:DC%2BC3MXnvVOhur0%3D
35. MG Lechner DJ Liebertz AL Epstein 2010 Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells J Immunol 185 4 2273 2284 20644162 10.4049/jimmunol. 1000901 1:CAS:528:DC%2BC3cXpslWnu7g%3D
36. P Cheng CA Corzo N Luetteke B Yu S Nagaraj MM Bui M Ortiz W Nacken C Sorg T Vogl J Roth DI Gabrilovich 2008 Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein J Exp Med 205 10 2235 2249 18809714 10.1084/jem.20080132 1:CAS:528:DC%2BD1cXht1SrtLvE
37. C De Santo R Arscott S Booth I Karydis M Jones R Asher M Salio M Middleton V Cerundolo 2010 Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A Nat Immunol 11 11 1039 1046 20890286 10.1038/ni.1942
38. V Huber S Fais M Iero L Lugini P Canese P Squarcina A Zaccheddu M Colone G Arancia M Gentile E Seregni R Valenti G Ballabio F Belli E Leo G Parmiani L Rivoltini 2005 Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: role in immune escape Gastroenterology 128 7 1796 1804 15940614 10.1053/j.gastro.2005.03.045 1:CAS:528:DC%2BD2MXlvFKls7w%3D (Pubitemid 40824690)
39. C Théry M Ostrowski E Segura 2009 Membrane vesicles as conveyors of immune responses Nat Rev Immunol 9 8 581 593 19498381 10.1038/nri2567
40. R Valenti V Huber P Filipazzi L Pilla G Sovena A Villa A Corbelli S Fais G Parmiani L Rivoltini 2006 Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes Cancer Res 66 18 9290 9298 16982774 10.1158/0008-5472.CAN-06-1819 1:CAS:528:DC%2BD28Xps1ahsrg%3D (Pubitemid 44521151)
41. F Chalmin S Ladoire G Mignot J Vincent M Bruchard JP Remy-Martin W Boireau A Rouleau B Simon D Lanneau A De Thonel G Multhoff A Hamman F Martin B Chauffert E Solary L Zitvogel C Garrido B Ryffel C Borg L Apetoh C Rébé F Ghiringhelli 2010 Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells J Clin Invest 120 2 457 471 20093776 1:CAS:528:DC%2BC3cXhsVOktL4%3D
42. ZG Fridlender J Sun S Kim V Kapoor G Cheng L Ling GS Worthen SM Albelda 2009 Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN Cancer Cell 16 3 183 194 19732719 10.1016/j.ccr.2009.06.017 1:CAS:528:DC%2BD1MXhsVChs7vN
43. A Mantovani S Sozzani M Locati P Allavena A Sica 2002 Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes Trends Immunol 23 11 549 555 12401408 10.1016/S1471-4906(02)02302-5 1:CAS:528:DC%2BD38XotVKktrc%3D (Pubitemid 35223554)
44. H van Cruijsen AA van der Veldt L Vroling D Oosterhoff HJ Broxterman RJ Scheper G Giaccone JB Haanen AJ van den Eertwegh E Boven K Hoekman TD de Gruijl 2008 Sunitinib-induced myeloid lineage redistribution in renal cell cancer patients: CD1c+ dendritic cell frequency predicts progression-free survival Clin Cancer Res 14 18 5884 5892 18794101 10.1158/1078-0432.CCR-08-0656
45. P Serafini K Meckel M Kelso K Noonan J Califano W Koch L Dolcetti V Bronte I Borrello 2006 Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function J Exp Med 203 12 2691 2702 17101732 10.1084/jem.20061104 1:CAS:528:DC%2BD28Xht12htLfL (Pubitemid 44833345)
46. N Mirza M Fishman I Fricke M Dunn AM Neuger TJ Frost RM Lush S Antonia DI Gabrilovich 2006 All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients Cancer Res 66 18 9299 9307 16982775 10.1158/0008-5472.CAN-06-1690 1:CAS:528:DC%2BD28Xps1ahsrk%3D (Pubitemid 44521152)
47. JS Ko AH Zea BI Rini JL Ireland P Elson P Cohen A Golshayan PA Rayman L Wood J Garcia R Dreicer R Bukowski JH Finke 2009 Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients Clin Cancer Res 15 6 2148 2157 19276286 10.1158/1078-0432.CCR-08-1332 1:CAS:528:DC%2BD1MXjtF2rurY%3D
48. PC Rodriguez MS Ernstoff C Hernandez M Atkins J Zabaleta R Sierra AC Ochoa 2009 Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes Cancer Res 69 4 1553 1560 19201693 10.1158/0008-5472.CAN-08-1921 1:CAS:528:DC%2BD1MXhslynsb4%3D
49. -/CD15+/CD33+ myeloid-derived suppressor cells and CD8 + T lymphocytes in patients with advanced-stage non-small cell lung cancer J Cancer Res Clin Oncol 136 1 35 45 19572148 10.1007/s00432-009-0634-0 1:CAS:528:DC%2BD1MXhsVertrjI
50. AI Daud N Mirza B Lenox S Andrews P Urbas GX Gao JH Lee VK Sondak AI Riker RC Deconti D Gabrilovich 2008 Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factor J Clin Oncol 26 19 3235 3241 18591558 10.1200/JCO.2007.13.9048 1:CAS:528:DC%2BD1cXptlKgtbY%3D
51. B Almand JI Clark E Nikitina J van Beynen NR English SC Knight DP Carbone DI Gabrilovich 2001 Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer J Immunol 166 1 678 689 11123353 1:CAS:528:DC%2BD3MXis1elsw%3D%3D (Pubitemid 32038493)
52. CA Corzo MJ Cotter P Cheng F Cheng S Kusmartsev E Sotomayor T Padhya TV McCaffrey JC McCaffrey DI Gabrilovich 2009 Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells J Immunol 182 9 5693 5701 19380816 10.4049/jimmunol.0900092 1:CAS:528:DC%2BD1MXkslKhs7g%3D
53. CA Corzo T Condamine L Lu MJ Cotter JI Youn P Cheng HI Cho E Celis DG Quiceno T Padhya TV McCaffrey JC McCaffrey DI Gabrilovich 2010 HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment J Exp Med 207 11 2439 2453 20876310 10.1084/jem.20100587 1:CAS:528:DC%2BC3cXhsVSktLzE
54. MK Srivastava JJ Bosch JA Thompson BR Ksander MJ Edelman S Ostrand-Rosenberg 2008 Lung cancer patients' CD4(+) T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells Cancer Immunol Immunother 57 10 1493 1504 18322683 10.1007/s00262-008-0490-9 1:CAS:528:DC%2BD1cXovFyitro%3D
55. DM Lathers JI Clark NJ Achille MR Young 2004 Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3 Cancer Immunol Immunother 53 5 422 430 14648070 10.1007/s00262-003-0459-7 1:CAS:528:DC%2BD2cXisVWhurg%3D (Pubitemid 38657255)
56. I Fricke N Mirza J Dupont C Lockhart A Jackson JH Lee JA Sosman DI Gabrilovich 2007 Vascular endothelial growth factor-trap overcomes defects in dendritic cell differentiation but does not improve antigen-specific immune responses Clin Cancer Res 13 16 4840 4848 17699863 10.1158/1078-0432.CCR-07-0409 1:CAS:528:DC%2BD2sXptVGmt7Y%3D (Pubitemid 47298146)